Table 2 Procedural details before and after propensity score matching
No diabetes (502) | Diabetes (250) | Before PS-matching | After PS-matching | |||||
|---|---|---|---|---|---|---|---|---|
Standardized mean difference | P value for difference | No diabetes (214) | Diabetes (214) | Standardized mean difference | P value for difference | |||
Isolated LMCA lesion | 76 (15.1%) | 12 (4.8%) | − 0.35 | < 0.001 | 20 (9.3%) | 10 (4.7%) | − 0.17 | 0.08 |
1-vessel disease (excluding LMCA) | 152 (30.3%) | 56 (22.4%) | − 0.22 | 0.02 | 63 (29.4%) | 46 (21.5%) | − 0.17 | 0.11 |
2-vessel disease (excluding LMCA) | 113 (22.5%) | 87 (34.8%) | 0.31 | 0.001 | 61 (28.5%) | 75 (35.1%) | 0.21 | 0.053 |
3-vessel disease (excluding LMCA) | 76 (15.1%) | 48 (19.2%) | 0.16 | 0.09 | 40 (18.7%) | 43 (20.1%) | 0.07 | 0.51 |
Rotational atherectomy | 55 (11.0%) | 55 (22.0%) | 0.3 | < 0.001 | 39 (18.2%) | 51 (23.8%) | 0.15 | 0.16 |
Intravascular imaging | 215 (42.8%) | 99 (39.6%) | − 0.07 | 0.38 | 84 (39.3%) | 85 (39.7%) | 0.01 | 0.92 |
IABP | 21 (4.2%) | 12 (4.8%) | 0.08 | 0.34 | 12 (5.6%) | 12 (5.6%) | 0 | 1.00 |
DES | 437 (87.1%) | 233 (93.2%) | 0.11 | 0.21 | 193 (90.2%) | 201 (93.9%) | 0.13 | 0.20 |
2-stent technique | 93 (18.5%) | 53 (21.2%) | 0.08 | 0.32 | 53 (24.8%) | 45 (21%) | − 0.1 | 0.34 |
LMCA stent diameter | 3.83 (0.38) | 3.69 (0.42) | − 0.35 | < 0.001 | 3.75 (0.39) | 3.68 (0.42) | − 0.2 | 0.04 |
LMCA-LAD stenting | 378 (75.3%) | 182 (72.8%) | − 0.12 | 0.14 | 168 (78.5%) | 157 (73.4%) | − 0.13 | 0.18 |
Final kissing balloon | 290 (57.8%) | 146 (58.4%) | − 0.03 | 0.76 | 127 (59.4%) | 122 (57%) | − 0.05 | 0.62 |
Contemporary treatment of another lesion | 162 (32.3%) | 103 (41.2%) | 0.16 | 0.06 | 84 (39.3%) | 88 (41.1%) | 0.04 | 0.66 |
Potent P2Y12 inhibitors | 81 (16.1%) | 40 (16%) | 0.01 | 0.93 | 29 (13.6%) | 36 (16.8%) | 0.1 | 0.32 |